HEPATITIS C AMONG NONINJECTING DRUG USERS: A REPORT
Explore this paper's citation graph
Summary
The results suggest that more research is needed to elucidate potential noninjecting routes of HCV transmission among drug users and policies that rely predominantly on injector status as the only drug-related risk factor for HCV screening need to be reassessed in light of these findings.
- Type
- article
- Published
- 2001-01-01
- Cited by
- 94
- References
- 22
- OpenAlex
- https://openalex.org/W2085129603
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:1763553
Keywords
Medicine, Drug, Hepatitis C, Hepatitis C virus, Transmission (telecommunications)
References
- Role of alcohol in the progression of liver disease caused by hepatitis C virus infection
- Hepatitis C virus infection in a male homosexual cohort: risk factor analysis.
- Chronic liver disease: Do alcohol and hepatitis C virus interact?
- TARGETED SAMPLING: OPTIONS FOR THE STUDY OF HIDDEN POPULATIONS
- Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts
- Absence of hepatitis C genome in semen of infected men by polymerase chain reaction, branched DNA and in situ hybridization.
- Impact of alcohol on the histological and clinical progression of Hepatitis C infection
- Hepatitis C Virus Infection in Chicago Women With or at Risk for HIV Infection: Evidence for Sexual Transmission
- Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study
- Absence of hepatitis C virus and detection of hepatitis G virus/GB virus C RNA sequences in the semen of infected men.
- Sexual transmission of hepatitis C virus infection.
- Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases.
- Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
- Respondent-driven sampling : A new approach to the study of hidden populations
- The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.
- Seroepidemiology of hepatitis C virus infection among drug abusers in southern Taiwan.
- Prevalence of hepatitis C virus infection in the United States.
- The detection, transmission, and outcome of hepatitis C virus infection.
- Targeted Sampling: Options for the Study of Hidden Populations
- Intrahepatic cholestasis of pregnancy
Cited by
- Primary and secondary prevention of hepatitis C virus among rural appalachian people who use drugs
- HCV (Hepatitis C Virus) Pre-Test and Post-Test Counseling Services at Drug Treatment Programs: Missed Opportunities for Primary Prevention
- Harm Reduction: Evidence, Impacts and Challenges
- High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack
- Crack use as a public health problem in Canada: call for an evaluation of 'safer crack use kits'.
- Women's Drug Injection Practices in East Harlem: An Event Analysis in a High-Risk Community
- Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users
- Rationale to Evaluate Medically Supervised Safer Smoking Facilities for Non-injection Illicit Drug Users
- Knowledge About Hepatitis-C Among Methadone Maintenance Treatment Patients in Israel
- Increasing Knowledge of HIV and Hepatitis C During Substance Abuse Treatment
- Hepatitis C Knowledge among Staff in U.S. Drug Treatment Programs
- Non-injection drug use and Hepatitis C Virus: a systematic review.
- Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment.
- Methamphetamine dependence: a closer look at treatment response and clinical characteristics associated with route of administration in outpatient treatment.
- A Trial to Reduce Hepatitis C Seroincidence In Drug Users
- Fumando La Piedra: Emerging Patterns of Crack Use Among Latino Immigrant Day Laborers in New Orleans
- Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use
- HIV and HCV Prevalence and Gender-Specific Risk Profiles of Crack Cocaine Smokers and Dual Users of Injection Drugs
- Psychiatric and Substance Use Disorders in Individuals with Hepatitis C
- Hepatitis C incidence—a comparison between injection and noninjection drug users in New York City
Related papers
- Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotype.
- Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels.
- Hepatitis C transmission – where are we now?
- Treatment of hepatitis C virus in the coinfected patient.
- New therapies for hepatitis C virus infection.
- Direct antiviral agents (DAAs) ‐ A new age in the treatment of hepatitis C virus infection
- Evidence for involvement of MHC restrictive mechanisms in hepatitis C virus (HCV) infection and HCV associated liver disease in renal transplant patients
- The detection of hepatitis C virus in South Hungary.
- Survival after liver transplantation for hepatocellular carcinoma in the model for end‐stage liver disease and pre–model for end‐stage liver disease eras and the independent impact of hepatitis C virus
- Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.